Interview with Rob Bootle: Advancements in Nanopharm’s OINDPs
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/ConversationsWithAnAptarPharmaExpert.jpg)
Join Rob Bootle as he explores his journey at Nanopharm, highlighting the company’s cutting-edge research and development in orally inhaled and nasal drug products (OINDPs).
Nanopharm Case Study on Computational Modelling
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/Case-Study-Using-modelling-to-accelerate-reformulation-of-an-injectable-drug-product-for-nasal-delivery.png)
Accelerate injectable drug reformulation for nasal delivery using modelling. Uncover clinical benefits and innovation in nasal pharmaceuticals.
Dual Excipient Integration in Dry Powder Inhaler Products
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm explore the effect of dual excipients on DPI products, boosting performance and shaping formulation in the dry powder inhaler landscape.